InstitutionMD Anderson
Address6767 Bertner St
Houston TX 77030-2603
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. McDaniel JM, Morrissey RL, Dibra D, Patel LR, Xiong S, Zhang Y, Chau GP, Su X, Qi Y, El-Naggar AK, Lozano G. p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator. Cancer Res Commun. 2024 Jul 12. PMID: 38994678.
      Citations:    Fields:    
    2. Dibra D, Xiong S, Moyer SM, El-Naggar AK, Qi Y, Su X, Kong EK, Korkut A, Lozano G. Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Sci Adv. 2024 Feb 16; 10(7):eadk1835. PMID: 38354236; PMCID: PMC10866549.
      Citations:    Fields:    Translation:HumansAnimalsCells
    3. Dibra D, Gagea M, Qi Y, Chau GP, Su X, Lozano G. p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis. Cancer Res Commun. 2023 12 29; 3(12):2640-2652. PMID: 38047594; PMCID: PMC10761659.
      Citations:    Translation:Animals
    4. Dibra D, Moyer SM, El-Naggar AK, Qi Y, Su X, Lozano G. Triple-negative breast tumors are dependent on mutant p53 for growth and survival. Proc Natl Acad Sci U S A. 2023 08 22; 120(34):e2308807120. PMID: 37579145; PMCID: PMC10450424.
      Citations: 5     Fields:    Translation:HumansAnimals
    5. Dibra D, Xia X, Gagea M, Lozano G, Li S. A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53. PLoS One. 2018; 13(3):e0193485. PMID: 29494633; PMCID: PMC5832250.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    6. Dibra D, Mitra A, Newman M, Xia X, Keenan C, Cutrera JJ, Mathis JM, Wang XJ, Myers J, Li S. IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin. Oncotarget. 2016 Nov 22; 7(47):77138-77151. PMID: 27738312; PMCID: PMC5363575.
      Citations: 4     Fields:    Translation:Animals
    7. Dibra D, Mitra A, Newman M, Xia X, Cutrera JJ, Gagea M, Kleinerman ES, Lozano G, Li S. Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo. Clin Cancer Res. 2016 08 01; 22(15):3876-83. PMID: 26979394; PMCID: PMC4970873.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    8. Dibra D, Xia X, Mitra A, Cutrera JJ, Lozano G, Li S. Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice. Hepatology. 2016 Mar; 63(3):1000-12. PMID: 26637970; PMCID: PMC4764463.
      Citations: 13     Fields:    Translation:AnimalsCells
    9. Yan J, Kong LY, Hu J, Gabrusiewicz K, Dibra D, Xia X, Heimberger AB, Li S. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. J Natl Cancer Inst. 2015 Aug; 107(8). PMID: 25971300; PMCID: PMC4554195.
      Citations: 49     Fields:    Translation:HumansAnimalsCells
    10. Dibra D, Mishra L, Li S. Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship. Biochim Biophys Acta. 2014 Aug; 1846(1):152-60. PMID: 24821201; PMCID: PMC4140981.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    11. Satelli A, Mitra A, Cutrera JJ, Devarie M, Xia X, Ingram DR, Dibra D, Somaiah N, Torres KE, Ravi V, Ludwig JA, Kleinerman ES, Li S. Universal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res. 2014 Mar 15; 74(6):1645-50. PMID: 24448245; PMCID: PMC3959622.
      Citations: 71     Fields:    Translation:HumansCells
    12. Dibra D, Li S. The cell-to-cell coordination between activated T cells and CpG-stimulated macrophages synergistically induce elevated levels of IL-10 via NF-?B1, STAT3, and CD40/CD154. Cell Commun Signal. 2013 Dec 13; 11:95. PMID: 24330710; PMCID: PMC3880105.
      Citations: 7     Fields:    Translation:AnimalsCells
    13. Cutrera J, Dibra D, Satelli A, Xia X, Li S. Intricacies for posttranslational tumor-targeted cytokine gene therapy. Mediators Inflamm. 2013; 2013:378971. PMID: 24369443; PMCID: PMC3863455.
      Citations: 3     Fields:    Translation:AnimalsCells
    14. Dibra D, Cutrera JJ, Li S. Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30. J Immunol. 2012 Apr 15; 188(8):3709-15. PMID: 22407920; PMCID: PMC3324657.
      Citations: 14     Fields:    Translation:AnimalsCells
    15. Dibra D, Cutrera J, Xia X, Kallakury B, Mishra L, Li S. Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology. 2012 Apr; 55(4):1204-14. PMID: 22105582; PMCID: PMC3295919.
      Citations: 25     Fields:    Translation:HumansAnimals
    16. Dibra D, Cutrera J, Xia X, Li S. WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells. PLoS One. 2011 Apr 29; 6(4):e19072. PMID: 21559505; PMCID: PMC3084744.
      Citations: 3     Fields:    Translation:AnimalsCells
    17. Cutrera J, Dibra D, Xia X, Hasan A, Reed S, Li S. Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy. Mol Ther. 2011 08; 19(8):1468-77. PMID: 21386825; PMCID: PMC3149172.
      Citations: 24     Fields:    Translation:Animals
    18. Cutrera J, Dibra D, Xia X, Li S. Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences. Cancer Gene Ther. 2010 Feb; 17(2):131-40. PMID: 19713998; PMCID: PMC2808434.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    19. Dibra D, Cutrera JJ, Xia X, Birkenbach MP, Li S. Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance. Cancer Res. 2009 Jul 01; 69(13):5505-13. PMID: 19549909; PMCID: PMC2706921.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    20. Role of IL12 family in regulation of antitumor immune response. 3-18.
    21. Lack of immunomodulatory interleukin-27 enhances oncogenic properties of mutant p53 in vivo. Clinical Cancer Research. 22:3876-3883.
    22. IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin. Oncotarget. 7:77138-77151.
    23. Erratum. Molecular Therapy. 20:1076.
    24. Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice. Hepatology.
    DIBRA's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (141)
    Co-Authors (12)
    Similar People (60)
    Same Department Expand Description